Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.35USD
16 Feb 2018
Change (% chg)

$0.10 (+1.38%)
Prev Close
$7.25
Open
$7.35
Day's High
$7.35
Day's Low
$7.35
Volume
1
Avg. Vol
2,661
52-wk High
$9.25
52-wk Low
$5.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 3.13 -0.038
Sep '17 2.00 -0.068
Jun '17 1.75 -0.045
Mar '17 3.54 0.118
FY 2016 Dec '16 2.21 0.009
Sep '16 1.97 0.008
Jun '16 2.38 -0.002
Mar '16 2.99 0.115
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. 112.19 280.23 46.75
P/E Low - Last 5 Yrs. 18.91 91.71 24.14
Beta 1.01 0.82 0.81
Price to Sales (TTM) 3.57 140.57 8.57
Price to Book (MRQ) -- 18.76 5.14
Price to Tangible Book (MRQ) -- 25.38 6.30
Price to Cash Flow (TTM) 55.73 118.58 25.75
% Owned Institutions 13.63 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 41.52 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago 9.30 45.64 7.30
Sales - 5 Yr. Growth Rate 14.12 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -535.58 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -125.46 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) -- 6.17 3.38
LT Debt to Equity (MRQ) -- 16.64 11.85
Total Debt to Equity (MRQ) -- 18.80 15.12
Interest Coverage (TTM) 8.32 -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.05 50.23 54.90
Gross Margin - 5 Yr. Avg. 55.70 55.34 52.64
EBITD Margin (TTM) 3.82 -- --
EBITD - 5 Yr. Avg 10.82 -567.40 9.86
Operating Margin (TTM) -2.32 -697.09 1.25
Operating Margin - 5 Yr. Avg. 5.81 -588.12 5.07
Pre-Tax Margin (TTM) -4.20 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. 5.33 -596.31 5.33
Net Profit Margin (TTM) -1.62 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. 3.43 -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. 35.56 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,305,201 819,569,446
Net Income/Employee (TTM) -- -626,600 95,804,981
Receivable Turnover (TTM) -- 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) -- 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -- -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -- -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % 9.29 11.15 14.12
EPS (TTM) % -128.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ImmuCell Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.63%
# of Holders: 21
Total Shares Held: 689,681
3 Mo. Net Change: 15,211
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 8
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.